Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Morava E, van den Heuvel L, Hol F, de Vries MC, Hogeveen M, Rodenburg RJ et al
Treatment requires monitoring of renal function, HbA1c, and body weight, with SGLT2 inhibitors temporarily discontinued during acute illness or before major surgery
mutations in OCTN2 lead to primary carnitine deficiency (PCD), a disorder characterized by systemic carnitine depletion and associated clinical manifestations, including muscle weakness, cardiomyopathy, and infertility
it works any time
US$ 24.48
US$ 25.30
US$ 23.74
